BofA/Merrill Lynch Downgrades Genomic Health Inc. (GHDX) to Underperform
Tweet Send to a Friend
BofA/Merrill Lynch downgraded Genomic Health Inc. (NASDAQ: GHDX) from Neutral to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
